We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Cytokinetics Announces Presentation of Data From a Phase IIa Clinical Trial of CK-2017357 in Patients With ALS at the 63rd Annual Meeting of the American Academy of Neurology

Product News   Apr 19, 2011

 
Cytokinetics Announces Presentation of Data From a Phase IIa Clinical Trial of CK-2017357 in Patients With ALS at the 63rd Annual Meeting of the American Academy of Neurology
FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

Medidata Supports Moderna’s COVID-19 Vaccine Clinical Trials with Rave Clinical Cloud Platform

Product News

Medidata is collaborating with Moderna, Inc. to support clinical trials of mRNA-1273, Moderna’s COVID-19 vaccine candidate.

READ MORE

Cytel Announces East Alloy: Easy Access to Bayesian and Innovative Methods

Product News

Cytel has announced the launch of East Alloy®, a web-native extension of Cytel’s East® software for adaptive clinical trial design and analysis.

READ MORE

Sinovac COVID-19 Vaccine Collaboration Receives Approval for Phase III Trial

Product News

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced an update to its previously announced partnership with Butantan, a leading Brazilian producer of immunobiologic products and vaccines.

READ MORE

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE